Nectar Lifescience Ltd

Nectar Lifesci. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Nectar Lifescience Ltd

₹ 38.7 4.99%
13 Dec - close price
neclife.com BSE: 532649 NSE: NECLIFE
About

Incorporated in 1995, Nectar Lifesciences
Ltd manufactures APIs and Formulations
and is also in the Menthol business[1]

Key Points

Business Overview:[1]
NLL is a research-driven manufacturer of Active Pharmaceutical Ingredients, intermediates, and finished dosage forms, specializing in anti-infectives like Cephalosporins. It also serves as a CMO for global pharma innovators.

Website BSE NSE - BE
  • Market Cap ₹ 869 Cr.
  • Current Price ₹ 38.7
  • High / Low ₹ 56.5 / 26.2
  • Stock P/E 80.9
  • Book Value ₹ 48.1
  • Dividend Yield 0.00 %
  • ROCE 5.97 %
  • ROE 0.45 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Stock is trading at 0.81 times its book value

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -9.57% over past five years.
  • Company has a low return on equity of -1.31% over last 3 years.
  • Promoters have pledged 100% of their holding.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
364.57 443.01 476.24 403.03 388.65 344.13 388.81 394.13 397.97 452.17 441.38 359.30 428.09
337.11 396.43 427.09 361.18 396.05 342.69 369.03 358.59 371.11 409.98 392.87 319.49 384.76
Operating Profit 27.46 46.58 49.15 41.85 -7.40 1.44 19.78 35.54 26.86 42.19 48.51 39.81 43.33
OPM % 7.53% 10.51% 10.32% 10.38% -1.90% 0.42% 5.09% 9.02% 6.75% 9.33% 10.99% 11.08% 10.12%
5.10 0.53 0.52 0.36 10.71 13.24 17.92 0.47 10.61 0.48 1.47 0.55 0.69
Interest 18.01 17.62 17.43 21.37 20.99 17.46 19.66 17.62 20.52 24.84 24.16 19.98 19.81
Depreciation 14.15 14.28 14.26 14.70 14.79 14.78 14.85 15.33 15.31 15.37 14.70 15.46 15.55
Profit before tax 0.40 15.21 17.98 6.14 -32.47 -17.56 3.19 3.06 1.64 2.46 11.12 4.92 8.66
Tax % -367.50% 36.09% 35.15% 35.99% -30.80% -47.10% -68.03% 40.52% 38.41% 36.18% 94.60% 39.63% 35.45%
1.86 9.73 11.66 3.94 -22.47 -9.29 5.36 1.82 1.02 1.57 0.60 2.97 5.60
EPS in Rs 0.08 0.43 0.52 0.18 -1.00 -0.41 0.24 0.08 0.05 0.07 0.03 0.13 0.25
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
1,622 1,634 1,638 1,675 1,635 1,873 2,781 2,360 1,539 1,664 1,522 1,682 1,681
1,332 1,345 1,371 1,436 1,411 1,637 2,517 2,142 1,430 1,506 1,467 1,530 1,507
Operating Profit 290 289 267 239 224 236 264 218 109 159 55 152 174
OPM % 18% 18% 16% 14% 14% 13% 10% 9% 7% 10% 4% 9% 10%
16 12 20 6 23 6 6 4 -22 11 43 15 3
Interest 115 138 126 123 117 115 148 126 112 79 79 87 89
Depreciation 76 84 77 57 62 64 63 61 60 57 59 61 61
Profit before tax 115 78 85 64 67 63 59 36 -85 34 -41 18 27
Tax % 25% 21% 22% 15% 18% 17% 19% 16% -14% 26% -45% 73%
86 62 66 54 55 52 47 30 -73 25 -22 5 11
EPS in Rs 3.82 2.77 2.95 2.42 2.46 2.33 2.11 1.34 -3.26 1.13 -1.00 0.22 0.48
Dividend Payout % 3% 4% 3% 4% 2% 2% 2% 4% -0% -0% -0% -0%
Compounded Sales Growth
10 Years: 0%
5 Years: -10%
3 Years: 3%
TTM: 10%
Compounded Profit Growth
10 Years: -23%
5 Years: -37%
3 Years: 28%
TTM: 1085%
Stock Price CAGR
10 Years: 2%
5 Years: 25%
3 Years: 10%
1 Year: 29%
Return on Equity
10 Years: 2%
5 Years: -1%
3 Years: -1%
Last Year: 0%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 22 22 22 22 22 22 22 22 22 22 22 22 22
Reserves 845 905 936 932 984 1,036 1,082 1,112 1,038 1,064 1,042 1,047 1,055
879 858 925 962 878 955 903 779 903 860 754 636 629
527 609 628 640 696 710 696 719 423 443 371 486 476
Total Liabilities 2,274 2,394 2,510 2,557 2,581 2,724 2,704 2,632 2,387 2,390 2,189 2,191 2,183
914 948 934 906 881 852 825 785 772 723 662 643 804
CWIP 139 122 91 99 102 100 100 115 99 85 78 66 57
Investments 0 0 1 1 1 1 1 1 1 1 1 1 1
1,221 1,324 1,485 1,551 1,597 1,771 1,778 1,732 1,515 1,580 1,449 1,482 1,321
Total Assets 2,274 2,394 2,510 2,557 2,581 2,724 2,704 2,632 2,387 2,390 2,189 2,191 2,183

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
361 255 144 169 199 65 239 286 21 95 133 225
-99 -90 -60 -77 -18 -29 -26 -33 -29 17 52 -17
-282 -161 -61 -89 -204 -40 -201 -252 11 -119 -186 -205
Net Cash Flow -20 4 23 3 -24 -4 12 1 4 -8 -0 2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 79 84 99 107 112 119 74 61 89 98 67 82
Inventory Days 216 240 253 260 270 226 150 192 185 197 212 215
Days Payable 122 139 146 154 167 142 79 104 108 112 100 127
Cash Conversion Cycle 172 185 207 213 215 203 145 149 166 183 178 170
Working Capital Days 137 152 173 178 186 190 129 149 190 198 204 171
ROCE % 13% 12% 11% 10% 10% 9% 10% 8% 3% 5% -0% 6%

Shareholding Pattern

Numbers in percentages

40 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
55.80% 55.80% 55.80% 55.80% 55.80% 55.80% 55.80% 55.80% 55.80% 55.80% 55.80% 55.80%
1.52% 1.67% 1.49% 16.12% 15.99% 16.07% 16.00% 16.02% 16.12% 16.98% 16.60% 3.24%
0.00% 0.00% 0.00% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%
42.68% 42.53% 42.72% 28.06% 28.20% 28.12% 28.18% 28.17% 28.05% 27.20% 27.57% 40.94%
No. of Shareholders 56,07364,01263,90962,94064,42262,87461,58260,28360,76159,94658,23066,741

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls

  • Nov 2024
    Transcript
    Notes
    PPT